+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis



Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis



Scandinavian Journal of Gastroenterology 49(7): 834-844



It has been considered that cesarean delivery is a risk factor for the two subtypes of inflammatory bowel diseases (IBDs): Crohn's disease (CD) and ulcerative colitis (UC). The aim of this meta-analysis was to examine the relationship between cesarean delivery and the development of IBD. We searched the articles retrieved by PubMed, MEDLINE and EMBASE databases to identify observational studies regarding the relationship between cesarean section and the development of CD and/or UC. Pooled odds ratios were calculated for each relationship. Nine studies evaluated the potential association between cesarean delivery and the development of IBD and met all of our inclusion criteria. The pooled data from six included studies indicated cesarean delivery was a risk factor for CD (95% confidence interval [CI]: 1.12-1.70; p = 0.003). Likewise, we observed a positive association between cesarean delivery and pediatric CD (95% CI: 1.06-1.35; p = 0.005). However, results from the four included studies for UC indicated the rate of cesarean section in UC patients was not higher than that of control subjects (95% CI: 0.87-1.32; p = 0.54). Overall, we did not observe a positive relationship between cesarean delivery and IBD (95% CI: 0.99-1.30; p = 0.08). Results of this meta-analysis support the hypothesis that cesarean delivery was associated with the risk of CD but not of UC. The total rate of cesarean delivery of IBD patients was similar with that of control subjects.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051999949

Download citation: RISBibTeXText

PMID: 24940636

DOI: 10.3109/00365521.2014.910834


Related references

Mode of delivery and risk of inflammatory bowel disease in the offspring: systematic review and meta-analysis of observational studies. Inflammatory Bowel Diseases 20(7): 1217-1226, 2014

Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. American Journal of Clinical Nutrition 80(5): 1342-1352, 2004

Tonsillectomy and the risk of inflammatory bowel disease: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology 31(6): 1085-1094, 2016

Inflammatory Bowel Disease is Associated with an Increased Risk of Melanoma A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 2013

Risk of Stroke in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Stroke and Cerebrovascular Diseases 24(12): 2774-2780, 2015

Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology 12(2): 210-218, 2014

The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis. Digestive and Liver Disease 51(1): 38-42, 2019

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 14(6): 798-806.E20, 2016

Sa1824 - Inflammatory Bowel Disease and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis. Gastroenterology 154(6): S-409-S-410, 2018

Mo1252 Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-Analysis. Gastroenterology 144(5): S-618-S-619, 2013

Sa1831 - Inflammatory Bowel Disease and Risk of Renal Cancer: A Systematic Review and Meta-Analysis. Gastroenterology 154(6): S-412, 2018

Relationship between NR1I2 polymorphisms and inflammatory bowel disease risk: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 41(2): 230-239, 2017

Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis. Bmc Gastroenterology 17(1): 52, 2017

Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. American Journal of Gastroenterology 102(3): 662-667, 2007

Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology 12(3): 382-93.E1: Quiz E22, 2014